Category: News

Categories
Long Post News

Happy to announce our fully renovated Discovery Lab and Headquarters, Sagres

Happy to announce our fully renovated Discovery Lab and Headquarters, Sagres

Our headquarters and Discovery Lab in Sagres has been fully renovated!

After a long and challenging process of plan-making and re-making, we have now a completely new Discovery Lab infrastructure to accommodate our field and sampling work. And fully equipped for our species identification, and where we can bring to light the potential of marine chemistries for human health.

Back to News

NEWS
Categories
News

Sea4Us is attending BioEurope 2022

Sea4Us is attending BioEurope 2022

Pedro Lima and Filipe Ceia will be attenting BioEurope 2022.

They will be presenting our work in marine pharmaceutical biotechnology, for the discovery of treatments for unmet clinical needs.

Look them up if you want to know more about our non-opioid solution for the treatment of chronic pain, and other pipelines.

Back to News

NEWS
Categories
News

Sea4Us Team Event and General Meeting in Sagres

Sea4Us Team Event and General Meeting in Sagres

After a long interruption, we could finally have our in person General Meeting.

We took the time to reflect on accomplishments and lessons learned, the challenges, our strengths, and the path ahead.

We had the opportunity to take an amazing boat trip and visit some of the places that we typically see as annotations from our Discovery team – the sources of our libraries and of the novel chemistries that inspire our solutions for human health. And the cherry on top? Being accompanied by dolphins in our ride.

It was great to be together. We are indeed a great team!

Back to News

NEWS
Categories
News

First in person General Assembly of Algae4IBD in Israel

First in person General Assembly of Algae4IBD in Israel

Marine resources have benefited society across centuries. Through Algae4IBD we are taking those lessons further, harnessing the immense potential of algae to tackle inflammatory bowel disease (IBD).

We have been developing the project for over 1y, and it is now time for our first General Assembly, in person and the beautiful country of Israel, discussing the health power of algae.

#Algae4IBD

Back to News

NEWS
Categories
News

End of 2nd round of med-chem for the analgesic compound – Lead Selected

End of 2nd round of med-chem for the analgesic compound - Lead Selected

We have just finished our second round of medicinal chemistry, for optimisation of our marine-derived analgesic compound for the treatment of chronic pain.

This round of molecular profile optimisation has enabled the selection of our Lead drug, from over 120 analogue candidates. This is an important milestone in our technology.

Back to News

NEWS
Categories
News

Sea4Us is attending UN2022 Ocean Conference

Sea4Us is attending UN2022 Ocean Conference

Pedro Lima, André Bastos, Tânia Ferreira and Filipe Ceia are attending the UN2022 Ocean Conference, in Lisbon.

As a marine pharmaceutical biotechnology company, we are intimately affected by the health of our Oceans. We seek to bring value to marine resources by their potential for human health, in a sustainable and responsible manner.

Join us to #saveouroceans

Back to News

NEWS
Categories
News

Blue BioEconomy Pact starts NOW

Blue BioEconomy Pact starts NOW

Today is the official start of activities for the Blue Bioeconomy Pact (BBP). 89 entities coming together to bring innovation to the Blue value chain, leveraging the sustainable use of marine bioresources.

BBP – To promote the development of sustainable innovative products from marine resources.

Innovation Pact Nº. C644915664-00000026

www.recuperarportugal.gov.pt

Back to News

NEWS
Categories
News

Sea4Us, SA

Sea4Us, SA

We are happy to announce that our company transitioned from a privately held limited company to a public limited company (SA). This transition marks an important milestone in our journey as a company, and we are thrilled to be taking this step forward.

This will allow us to broaden our investor base and access new sources of capital, which will help us to continue to grow and expand our business. It will also provide greater transparency and accountability to our shareholders and stakeholders.

Our mission remains unchanged: to develop new technologies for the treatment of unmet clinical needs.

Back to News

NEWS
Categories
News

New partners to join Sea4Us

New partners to join Sea4Us

We are pleased to announce that our company has recently welcomed 3 new investors, that share our mission and values, to bring new treatments for unmet clinical needs. This will allow us to grow, meet important upcoming milestones for our R&D pipelines, and mature our technologies.

We are excited to have them on board, and we would like to express our gratitude to all our shareholders, employees, and partners for their continued support.

Back to News

NEWS